Skip header and navigation
The BC Cancer Library

Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.

  Refine by:

Refine by:

Format

4 records – page 1 of 1.

Combined estrogen-progestogen contraceptives|and combined estrogen-progestogen menopausal therapy

https://bccalibrary.andornot.com/en/permalink/catalog16349
International Agency for Research on Cancer, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2005 June 7-14 : Lyon, France), World Health Organization. Lyon, France: International Agency for Research on Cancer , 2007.
Audience
Professional
Call Number
QZ202 I585 2007 v.91
Availability
1 copy, 1 available
More Information
  2 read online  
Corporate Author
International Agency for Research on Cancer
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2005 June 7-14 : Lyon, France)
World Health Organization
Place of Publication
Lyon, France
Publisher
International Agency for Research on Cancer
Publication Date
2007
Physical Description
ix, 528 p. : ill. ; 24 cm.
Series
IARC monographs on the evaluation of carcinogenic risks to humans 91
Subjects
Contraceptives, Oral, Hormonal - adverse effects
Estrogens - therapeutic use
Hormone Replacement Therapy - adverse effects
Neoplasms - chemically induced
Neoplasms - prevention & control
Progestins - adverse effects
Progestins - therapeutic use
ISBN
9789283212911
ISSN
1017-1606
Language
English
Material Type
Book
Online
Audience
Professional
Location
Vancouver Library
Internet
Call Number
QZ202 I585 2007 v.91
Read Online
http://monographs.iarc.fr/ENG/recentpub/mono91.pdf
http://monographs.iarc.fr/ENG/Monographs/vol91/index.php

Copies

c.1 BC Cancer Agency VAN Library Available
Show Less

Hormonal contraception and post-menopausal hormonal therapy

https://bccalibrary.andornot.com/en/permalink/catalog3851
International Agency for Research on Cancer. Lyon, France: International Agency for Research on Cancer , 1999.
Audience
Professional
Call Number
QZ202 I585 1999 v.72
Availability
1 copy, 1 available
More Information
  2 read online  
Corporate Author
International Agency for Research on Cancer
Place of Publication
Lyon, France
Publisher
International Agency for Research on Cancer
Publication Date
1999
Subjects
Carcinogens
Hormones - adverse effects
Estrogen Replacement Therapy - adverse effects
Contraception, Oral - adverse effects
ISBN
928321072X
Language
English
Material Type
Book
Online
Audience
Professional
Location
Vancouver Library
Internet
Call Number
QZ202 I585 1999 v.72
Read Online
http://monographs.iarc.fr/ENG/Monographs/vol72/index.php
http://monographs.iarc.fr/ENG/Monographs/vol72/mono72.pdf

Copies

c.1 BC Cancer Agency VAN Library Available
Show Less

Hormone-related malignant tumors

https://bccalibrary.andornot.com/en/permalink/catalog6929
New York, NY: Springer-Verlag , 1990.
Audience
Professional
Call Number
QZ206 RE34 1990 v.118
Availability
1 copy, 1 available
More Information
Editor
Beck, Lutwin
Grundemann, Ekkehard
Ackermann, Rolf
Roeher, Hans-Dietrich
Place of Publication
New York, NY
Publisher
Springer-Verlag
Publication Date
1990
Series
Recent results in cancer research 118
Subjects
Hormones - adverse effects - congresses
Neoplasms - drug therapy
ISBN
837512586
Language
English
Material Type
Book
Audience
Professional
Location
Vancouver Library
Call Number
QZ206 RE34 1990 v.118

Copies

c.1 BC Cancer Agency VAN Library Available
Show Less

RANK ligand : a key signal in cancer-induced bone disease and hormone ablative therapy-induced bone loss

https://bccalibrary.andornot.com/en/permalink/catalog19811
Amgen Inc. Thousand Oaks, Calif.: Amgen Inc. , 2009.
Audience
Professional
Call Number
WE258 R198 2009
Availability
1 copy, 1 available
Introduction; RANK ligand in bone biology; Bone metastases; Multiple myeloma; Skeletal-related events (SREs); Hormone ablative therapy-induced bone loss
More Information
Author
Amgen Inc.
Place of Publication
Thousand Oaks, Calif.
Publisher
Amgen Inc.
Publication Date
2009
Subjects
RANK Ligand - metabolism
Osteoblasts
Osteoclasts
Antibodies, Monoclonal - therapeutic use
Bone Neoplasms - secondary
Bone Resorption
Osteoporosis - therapy
Antineoplastic Agents, Hormonal - adverse effects
Abstract
Introduction
RANK ligand in bone biology
Bone metastases
Multiple myeloma
Skeletal-related events (SREs)
Hormone ablative therapy-induced bone loss
Language
English
Material Type
Video
DVD
Audience
Professional
Location
Abbotsford Library
Call Number
WE258 R198 2009

Copies

c.1 BC Cancer Agency ARHCC Library Available
Show Less